Illustration: Sarah Grillo/Axios
FFL Partners is seeking to sell ambulatory infusion therapy provider Apex Infusion, two sources tell Axios Pro.
Why it matters: The PE-backed infusion market has been busy, but deal closes have been challenging as buyers become more selective.
